Ventilator associated pneumonia (VAP) is a type of nosocomial pneumonia associated with increased morbidity and mortality. Knowledge about the incidence and risk factors is necessary to implement preventive measures to reduce mortality in these patients. Method A prospective study was conducted at a tertiary care teaching hospital for a period of 20 months from November 2009 to July 2011. Patients who were on mechanical ventilation (MV) for more than 48 hours were monitored at frequent intervals for development of VAP using clinical and microbiological criteria until discharge or death.
Background
Ventilator associated pneumonia (VAP) is a type of nosocomial pneumonia which occurs in patients who receive mechanical ventilation (MV) via tracheal or tracheostomy tube. 1 Differences in VAP incidences have been based on the antibiotic profile, ICU environment, and the population of study. 2 According to The National Nosocomial Infection Surveillance Program the incidence of VAP is 7.6 cases per 1000 patient ventilator days. 3 The incidence of VAP ranges from 28-32%. 4, 5 This difference is a result of the diversity of diagnostic methods used. Development of VAP ≤ 96 hours of MV is classified as early onset; a delay of more than 96 hours is termed as late onset. 6 Intubation alone is a risk factor for the development of pneumonia among hospitalised patients. 7 Both the host and intervention associated risk factors increase the mortality among these patients. 1 The end result is either colonisation or aspiration of the respiratory contents with potential pathogens. 8, 9 The mortality rate among these patients ranges from 16-20%. 6,10 A study of both incidence and risk factors was necessary to implement preventive measures and thereby reduce mortality rate in these patients.
Method
Study design A prospective study was conducted at a tertiary care teaching hospital over a period of 20 months from November 2009 to July 2011. All patients admitted in the ICU who received MV were included in the study. Patients who were mechanically ventilated for less than 48 hours and those who had developed pneumonia prior to initiation of MV were excluded from the study. The study was approved by the institute ethics committee. Informed consent was obtained from the patient's next of kin. 
Data collection
The following variables were collected: age, sex, provisional diagnosis, date of hospital admission, and duration of MV. The patients included in this study were monitored at frequent intervals (every 48 hours) for the development of VAP using clinical and microbiological criteria till discharge or death. The parameters such as fever, chest X-ray, oxygenation, leukocytosis, and other risk factors were collected every 48 hours.
Microbiological methods
EA was serially diluted in sterile normal saline as 1/10, 1/100, 1/1000 and 0.01 ml of 1/1000 dilution was inoculated on 5% sheep blood agar. After incubation at 37 o C in 5% CO2 incubator for 24 hours, colony count was completed and expressed as number of colony forming units per ml (CFU/ml). The number of CFU/ ml is equal to number of colonies on agar plate  dilution factor  inoculation factor. Therefore, the presence of a single colony on the blood agar after inoculating 0. Univariate analysis indicated that chronic lung failure, use of H2 blockers, and supine head position were significantly associated with VAP (Table 3) . Selected risk factors were entered into a logistic regression model to perform the multivariate analysis which revealed that supine head position was an independent risk factor for VAP (Table 4) . Parameter Non-VAP VAP (n = 18) P value (n = 58) (2-tailed) Age (mean ± SD) 48.2 ± 18.4 47.8 ± 17.8 0.94 
Discussion
Ventilator associated pneumonia is a type of nosocomial infection acquired in the ICU. We observed that the incidence of VAP was about 23.7%, which is comparable to the observations made in several other studies. In a study conducted from four multidisciplinary intensive care units from Greece the incidence was reported to be 32%. 4 In a evaluation made in Boston, VAP was reported at the rate of 10.2% per 1000 ventilator days. 17 Similarly Gupta A and coworkers, reported an incidence of 28.0%. 5 In a study from South India the incidence was reported to be 18%. VAP is generally classified as early onset and late onset based on the time of onset of VAP. In our study, early onset VAP occurred in 13 (72.2%) patients, while late onset VAP was observed in the remaining 5 (27.8%) individuals. Other studies have reported early-onset VAP in almost half of all VAP episodes. 18, 19 We observed that about 94% (17 out of 18) of VAP cases occurred within the first week of mechanical ventilation. Apostolopoulou et al also had documented that there was an increased risk of developing VAP during the first two weeks of MV. The increased risk is mainly attributed to the interaction of several risk factors during the initial days of MV. 4 The patients who developed VAP in the present study were admitted for various clinical disorders. There was no significant association between the occurrence of VAP and the primary diagnosis of the patients, however the small number of patients in our study group could have resulted in our failure to find significant associations in our subgroups. For example, in a similar study from South India, patients with neurological disorders and CNS infections were observed to be significantly predisposed for the development of VAP. 6 In other studies intra-abdominal diseases and multiple injury were noted to be significant predisposing factors for VAP. 2, 4, 18 Risk factors for the development of VAP were evaluated in the present study. The host and intervention factors such as, age ≥ 60 years, organ failure, abdominal or thoracic surgery, ARDS, chronic lung failure, impaired consciousness, tracheostomy, nasogastric tube, H2 blockers, supine head position, steroids usage, and emergency intubation were evaluated. We observed chronic lung failure, H2 blockers usage, and supine head position were significantly associated with VAP by univariate analysis, while supine head position was found to be the only independent risk factor for VAP by logistic regression. The defective lung function along with the pre-existing lung damage in patients with chronic lung failure may be responsible for the increased occurrence of VAP in these patients. Similarly, H2 blockers usage was associated with an increased risk as it can alter the gastric pH thereby facilitating organism multiplication which, when aspirated, can lead to occurrence of VAP. Supine head position increases the risk of aspiration of the gastric contents and could explain some of the increase in the rate of VAP in critically ill patients. Awareness of these risk factors can aid in identification of patients at higher risk, guide institution of appropriate preventive measures, and modulate potential intervention measures while managing such patients. Supine head position, stress ulcer prophylaxis, surgery, burns, chronic renal failure, trauma, steroid therapy and duration of MV ≥ 5d were documented as risk factors in other studies. 2, 18 In another study, impaired consciousness, tracheostomy, reintubation, emergency intubation, and nasogastric tube were found to be independent risk factors for VAP. 6 Awareness of these risk factors helps to overcome the adverse effects of VAP.
Conclusion
VAP, an important nosocomial infection among the critically ill patients, requires purposeful study to reduce mortality. Good knowledge of VAP and its associated parameters is important. Despite the small sample size which is a limitation of our study, our findings emphasize the importance of the several risk factors for VAP. Further studies on incidence and risk factors can facilitate knowledge translation activities about the disease and thereby minimise the occurrence of VAP through the implemention of simple, low cost preventive measures. Awareness about the various risk factors will aid in reduction of the morbidity and mortality associated with VAP.
